Amifostine in the treatment of head and neck cancer: intravenous administration, subcutaneous administration, or none of the above.
Avraham
A
Eisbruch
D004999:Amifostine / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D007262:Infusions, Intravenous; D055104:Infusions, Subcutaneous; D011837:Radiation-Protective Agents / Q000008:administration & dosage*
D011837:Radiation-Protective Agents; D004999:Amifostine